Literature DB >> 15219259

Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat.

Harry J Gould1, John D England, R Denis Soignier, Porter Nolan, Lerna D Minor, Z P Liu, S Rock Levinson, Dennis Paul.   

Abstract

UNLABELLED: Although nerve growth factor plays a role in augmenting sodium channel expression in small dorsal root ganglion (DRG) cells, the cytochemical mediators responsible for enhanced expression in large DRG neurons are unknown. To narrow the search for mediators involved in the increased production of sodium channels in large DRG neurons, we examined the effect of cyclooxygenase inhibition on sodium channel production during inflammation. Thirty minutes before the subcutaneous injection of complete Freund's adjuvant (CFA), rats received ibuprofen (nonselective, cyclooxygenase inhibitor), NS-398 (selective, cyclooxygenase inhibitor), or vehicle. Withdrawal thresholds from thermal and mechanical stimulation were measured before and immediately after CFA injection and at selected hourly intervals after injection for the next 24 hours. Sodium channel up-regulation was then examined in DRG by using site-specific, anti-sodium channel antibodies, Na(v) 1.7 and 1.8. Both ibuprofen and NS-398 provided analgesia during the second phase of inflammatory hyperalgesia that begins 3 hours after CFA injection. The up-regulation, predominantly of Na(v) 1.7 and minimally of Na(v) 1.8 channels, seen in vehicle-treated rats was suppressed by both drugs at 24 hours after injection. By 72 hours after injection, no difference in labeling between the drug- and vehicle-treated animals was observed. Sodium channel labeling in large DRG neurons returned to baseline between 1 and 2 weeks after CFA injection, whereas small cell labeling persisted. The cytochemical signal for sodium channel up-regulation in the large DRG cells that most closely correlates with inflammatory hyperalgesia is mediated at least in part through products of the cyclooxygenase pathway. PERSPECTIVE: Expression of sodium channels in dorsal root ganglia increases dramatically during inflammation. The increase in sodium channels is thought to enhance neuronal excitability and to play a role in hyperalgesia and wound vigilance during healing. We provide evidence that prostaglandins play a role in signaling channel augmentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219259     DOI: 10.1016/j.jpain.2004.04.005

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  39 in total

Review 1.  Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations.

Authors:  Ron Dabby
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 2.  Na(+) channel blockers for the treatment of pain: context is everything, almost.

Authors:  Michael S Gold
Journal:  Exp Neurol       Date:  2007-12-08       Impact factor: 5.330

Review 3.  A brief comparison of the pathophysiology of inflammatory versus neuropathic pain.

Authors:  Qinghao Xu; Tony L Yaksh
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

Review 4.  Effect of preoperative oral analgesics on pulpal anesthesia in patients with irreversible pulpitis-a systematic review and meta-analysis.

Authors:  Armin Shirvani; Sayna Shamszadeh; Mohammad Jafar Eghbal; Laleh Alim Marvasti; Saeed Asgary
Journal:  Clin Oral Investig       Date:  2016-11-11       Impact factor: 3.573

5.  Pain management for dentists: the role of ibuprofen.

Authors:  Alessandro Pozzi; Luca Gallelli
Journal:  Ann Stomatol (Roma)       Date:  2012-04-15

Review 6.  The role of sodium channels in chronic pain.

Authors:  Simon R Levinson; Songjiang Luo; Michael A Henry
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

7.  Prostaglandin E2 Upregulated Trigeminal Ganglionic Sodium Channel 1.7 Involving Temporomandibular Joint Inflammatory Pain in Rats.

Authors:  Peng Zhang; Ye-Hua Gan
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

8.  Ranolazine attenuates behavioral signs of neuropathic pain.

Authors:  Harry J Gould; Colleen Garrett; Renee R Donahue; Dennis Paul; Ivan Diamond; Bradley K Taylor
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

9.  PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons.

Authors:  Chun-Lei Cang; Hua Zhang; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

10.  Enhanced excitability of MRGPRA3- and MRGPRD-positive nociceptors in a model of inflammatory itch and pain.

Authors:  Lintao Qu; Ni Fan; Chao Ma; Tao Wang; Liang Han; Kai Fu; Yingdi Wang; Steven G Shimada; Xinzhong Dong; Robert H LaMotte
Journal:  Brain       Date:  2014-02-18       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.